Laurence Hicks - Net Worth and Insider Trading

Laurence Hicks Net Worth

The estimated net worth of Laurence Hicks is at least $11,270 dollars as of 2024-06-17. Laurence Hicks is the Director of Arch Therapeutics Inc and owns about 10,292 shares of Arch Therapeutics Inc (ARTH) stock worth over $11,270. Details can be seen in Laurence Hicks's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Laurence Hicks has not made any transactions after 2023-08-31 and currently still holds the listed stock(s).

Transaction Summary of Laurence Hicks

To

Laurence Hicks Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Laurence Hicks owns 1 companies in total, including Arch Therapeutics Inc (ARTH) .

Click here to see the complete history of Laurence Hicks’s form 4 insider trades.

Insider Ownership Summary of Laurence Hicks

Ticker Comapny Transaction Date Type of Owner
ARTH Arch Therapeutics Inc 2023-08-31 director

Laurence Hicks Latest Holdings Summary

Laurence Hicks currently owns a total of 1 stock. Laurence Hicks owns 10,292 shares of Arch Therapeutics Inc (ARTH) as of August 31, 2023, with a value of $11,270.

Latest Holdings of Laurence Hicks

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ARTH Arch Therapeutics Inc 2023-08-31 10,292 1.10 11,270

Holding Weightings of Laurence Hicks


Laurence Hicks Form 4 Trading Tracker

According to the SEC Form 4 filings, Laurence Hicks has made a total of 1 transactions in Arch Therapeutics Inc (ARTH) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Arch Therapeutics Inc is the acquisition of 10,292 shares on August 31, 2023, which cost Laurence Hicks around $2,882.

Insider Trading History of Laurence Hicks

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Laurence Hicks Trading Performance

GuruFocus tracks the stock performance after each of Laurence Hicks's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Laurence Hicks is 335.37%. GuruFocus also compares Laurence Hicks's trading performance to market benchmark return within the same time period. The performance of stocks bought by Laurence Hicks within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Laurence Hicks's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Laurence Hicks

Average Return

No transaction record over 1 Year.

Outperforming Transactions

No transaction record over 1 Year.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -11.56 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -6.69 LIMIT LIMIT LIMIT LIMIT LIMIT

Laurence Hicks Ownership Network

Ownership Network List of Laurence Hicks

No Data

Ownership Network Relation of Laurence Hicks

Insider Network Chart

Laurence Hicks Owned Company Details

What does Arch Therapeutics Inc do?

Who are the key executives at Arch Therapeutics Inc?

Laurence Hicks is the director of Arch Therapeutics Inc. Other key executives at Arch Therapeutics Inc include director & President & CEO Terrence W Norchi , CFO and Treasurer Michael S Abrams , and Vice President & Sales Dan Yrigoyen .

Arch Therapeutics Inc (ARTH) Insider Trades Summary

Over the past 18 months, Laurence Hicks made 1 insider transaction in Arch Therapeutics Inc (ARTH) with a net purchase of 10,292. Other recent insider transactions involving Arch Therapeutics Inc (ARTH) include a net purchase of 10,292 shares made by Michael S Abrams , a net purchase of 6,862 shares made by Terrence W Norchi ,

In summary, during the past 3 months, insiders sold 0 shares of Arch Therapeutics Inc (ARTH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Arch Therapeutics Inc (ARTH) were sold and 27,446 shares were bought by its insiders, resulting in a net purchase of 27,446 shares.

Arch Therapeutics Inc (ARTH)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Arch Therapeutics Inc Insider Transactions

No Available Data

Laurence Hicks Mailing Address

Above is the net worth, insider trading, and ownership report for Laurence Hicks. You might contact Laurence Hicks via mailing address: C/o Arch Therapeutics, Inc., 235 Walnut Street, Suite 6, Framingham Ma 01702.

Discussions on Laurence Hicks

No discussions yet.